Abbott Recalls Fourth Powdered Infant Formula Linked to Illness
(Bloomberg) -- Abbott Laboratories'Â embattled nutrition unit has added a fourth product to its recall of powdered infant formulas tied to a facility in Michigan.
The U.S. Food and Drug Administration on Monday announced the recall of Similac PM 60/40, Abbott's specialized low-mineral baby formula. That followed a U.S. Centers for Disease Control and Prevention report that an infant was infected with Cronobacter sakazakii after being exposed to the powdered formula. The infant later died, the agency said on its website.
The specialized formula wasn't part of Abbott's Feb. 17 recall of some Similac, EleCare and Alimentum formulas produced at the facility in Sturgis, Michigan. Those products were linked to four cases of cronobacter and salmonella infections, leading to one death. Cans of Similac PM 60/40 with lot code 27032K80  and cases coded 27032K800 are the only ones being recalled, according to the FDA.Â
Cronobacter sakazakii infection can cause sepsis and meningitis, which can be deadly in newborns, according to the CDC. Â
In an email statement, an Abbott spokeswoman said the cases are under investigation and the cause of the infections hasn't been determined. The company said all infant formula products are tested and must test negative for Cronobacter sakazakii, salmonella and other pathogens before they're released.
Abbott shares were up 1.3% as of 11 a.m. Wednesday in New York.
Even before the latest recalls, parents nationwide were dealing with formula shortages due in part to supply chain issues affecting certain ingredients as well as insufficient staff. Shortages can pose problems for parents who often don't want to switch formula brands from week to week after finding one that works for their infant.
In their recall announcement, the FDA said consumers can keep using all products that aren't included in the recalls, and that parents shouldn't dilute formula or make their own.
The earlier recall cited Abbott products bearing a multidigit number on the formula container bottom starting with the first two digits 22 through 37, containing the letters and numbers K8, SH or Z2 and with an expiration date of April 1, 2022.
The FDA also partnered with the Department of Agriculture's Food and Nutrition Service in order to monitor how the recall impacts the Special Supplemental Nutrition Program for Women, Infants, and Children for low-income families. Program participants affected by the recalls should be able to obtain different brands or similar formula, according to the FDA.
©2022 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.